OBJECTIVE: Research on depression among HIV-positive patients has been limited by the lack of a valid and reliable measure of depression. This project addresses this problem by exploring the internal consistency reliability and the concurrent and discriminant validity of the Beck Depression Inventory-II (BDI-II) using HIV-positive patients in Jamaica. METHOD: Patients from three HIV clinics in Jamaica (n = 191 patients; 61% female, 39% male, mean age 40.5-10 years) were administered the BDI-II along with the Centre for Epidemiological Studies -Depression Scale (CES-D) and the Social Provisions Scale. RESULTS: Overall, the BDI-II was found to have a high degree of reliability (alpha = 0.89). The scale also had good concurrent validity as evidenced by a high correlation with scores on the CES-D (r = 0.74) and acceptable discriminant validity as demonstrated through a moderate correlation with the Social Provisions Scale (r = -0.42). This pattern of scores suggests that the majority of the variance underlying the BDI-II assesses depression (55%) while a smaller degree of the variability (18%) measures a conceptually similar but distinct concept. CONCLUSION: The BDI-II is a sufficiently reliable and valid measure for assessing depression in HIV-positive patients.
OBJECTIVE: Research on depression among HIV-positivepatients has been limited by the lack of a valid and reliable measure of depression. This project addresses this problem by exploring the internal consistency reliability and the concurrent and discriminant validity of the Beck Depression Inventory-II (BDI-II) using HIV-positivepatients in Jamaica. METHOD:Patients from three HIV clinics in Jamaica (n = 191 patients; 61% female, 39% male, mean age 40.5-10 years) were administered the BDI-II along with the Centre for Epidemiological Studies -Depression Scale (CES-D) and the Social Provisions Scale. RESULTS: Overall, the BDI-II was found to have a high degree of reliability (alpha = 0.89). The scale also had good concurrent validity as evidenced by a high correlation with scores on the CES-D (r = 0.74) and acceptable discriminant validity as demonstrated through a moderate correlation with the Social Provisions Scale (r = -0.42). This pattern of scores suggests that the majority of the variance underlying the BDI-II assesses depression (55%) while a smaller degree of the variability (18%) measures a conceptually similar but distinct concept. CONCLUSION: The BDI-II is a sufficiently reliable and valid measure for assessing depression in HIV-positivepatients.
Authors: John R Keltner; Colm G Connolly; Florin Vaida; Mark Jenkinson; Christine Fennema-Notestine; Sarah Archibald; Cherine Akkari; Alexandra Schlein; Jisu Lee; Dongzhe Wang; Sung Kim; Han Li; Austin Rennels; David J Miller; George Kesidis; Donald R Franklin; Chelsea Sanders; Stephanie Corkran; Igor Grant; Gregory G Brown; J Hampton Atkinson; Ronald J Ellis Journal: Pain Med Date: 2017-03-01 Impact factor: 3.750
Authors: John R Keltner; Christine Fennema-Notestine; Florin Vaida; Dongzhe Wang; Donald R Franklin; Robert H Dworkin; Chelsea Sanders; J Allen McCutchan; Sarah L Archibald; David J Miller; George Kesidis; Clint Cushman; Sung Min Kim; Ian Abramson; Michael J Taylor; Rebecca J Theilmann; Michelle D Julaton; Randy J Notestine; Stephanie Corkran; Mariana Cherner; Nichole A Duarte; Terry Alexander; Jessica Robinson-Papp; Benjamin B Gelman; David M Simpson; Ann C Collier; Christina M Marra; Susan Morgello; Greg Brown; Igor Grant; J Hampton Atkinson; Terry L Jernigan; Ronald J Ellis Journal: J Neurovirol Date: 2014-02-19 Impact factor: 2.643
Authors: Angela Ofori-Atta; Nancy R Reynolds; Sampson Antwi; Lorna Renner; Justin S Nichols; Margaret Lartey; Kofi Amissah; Jonas Kusah Tettey; Amina Alhassan; Irene Pokuaa Ofori; Ann C Catlin; Geliang Gan; Tassos C Kyriakides; Elijah Paintsil Journal: AIDS Care Date: 2018-10-25
Authors: Andréa L Hobkirk; Amy J Starosta; Joseph A De Leo; Christina M Marra; Robert K Heaton; Mitch Earleywine Journal: Psychol Assess Date: 2014-11-24